3 February 2023 - The Inflation Reduction Act of 2022 marks the first major overhaul of the Medicare Part D prescription drug benefit in over a decade.
Media coverage has largely focused on one Medicare reform enacted through the Inflation Reduction Act—a $2,000 limit on annual Part D out of pocket prescription costs starting in 2025.